288 related articles for article (PubMed ID: 29790943)
1. Mutalisk: a web-based somatic MUTation AnaLyIS toolKit for genomic, transcriptional and epigenomic signatures.
Lee J; Lee AJ; Lee JK; Park J; Kwon Y; Park S; Chun H; Ju YS; Hong D
Nucleic Acids Res; 2018 Jul; 46(W1):W102-W108. PubMed ID: 29790943
[TBL] [Abstract][Full Text] [Related]
2. Mutation Signatures Depend on Epigenomic Contexts.
Coleman N; De S
Trends Cancer; 2018 Oct; 4(10):659-661. PubMed ID: 30292349
[TBL] [Abstract][Full Text] [Related]
3. Cell-of-origin chromatin organization shapes the mutational landscape of cancer.
Polak P; Karlić R; Koren A; Thurman R; Sandstrom R; Lawrence M; Reynolds A; Rynes E; Vlahoviček K; Stamatoyannopoulos JA; Sunyaev SR
Nature; 2015 Feb; 518(7539):360-364. PubMed ID: 25693567
[TBL] [Abstract][Full Text] [Related]
4. Local Determinants of the Mutational Landscape of the Human Genome.
Gonzalez-Perez A; Sabarinathan R; Lopez-Bigas N
Cell; 2019 Mar; 177(1):101-114. PubMed ID: 30901533
[TBL] [Abstract][Full Text] [Related]
5. Signatures of mutational processes in human cancer.
Alexandrov LB; Nik-Zainal S; Wedge DC; Aparicio SA; Behjati S; Biankin AV; Bignell GR; Bolli N; Borg A; Børresen-Dale AL; Boyault S; Burkhardt B; Butler AP; Caldas C; Davies HR; Desmedt C; Eils R; Eyfjörd JE; Foekens JA; Greaves M; Hosoda F; Hutter B; Ilicic T; Imbeaud S; Imielinski M; Jäger N; Jones DT; Jones D; Knappskog S; Kool M; Lakhani SR; López-Otín C; Martin S; Munshi NC; Nakamura H; Northcott PA; Pajic M; Papaemmanuil E; Paradiso A; Pearson JV; Puente XS; Raine K; Ramakrishna M; Richardson AL; Richter J; Rosenstiel P; Schlesner M; Schumacher TN; Span PN; Teague JW; Totoki Y; Tutt AN; Valdés-Mas R; van Buuren MM; van 't Veer L; Vincent-Salomon A; Waddell N; Yates LR; ; ; ; ; Zucman-Rossi J; Futreal PA; McDermott U; Lichter P; Meyerson M; Grimmond SM; Siebert R; Campo E; Shibata T; Pfister SM; Campbell PJ; Stratton MR
Nature; 2013 Aug; 500(7463):415-21. PubMed ID: 23945592
[TBL] [Abstract][Full Text] [Related]
6. Intrinsic Molecular Processes: Impact on Mutagenesis.
Lim B; Mun J; Kim SY
Trends Cancer; 2017 May; 3(5):357-371. PubMed ID: 28718413
[TBL] [Abstract][Full Text] [Related]
7. Exploring background mutational processes to decipher cancer genetic heterogeneity.
Goncearenco A; Rager SL; Li M; Sang QX; Rogozin IB; Panchenko AR
Nucleic Acids Res; 2017 Jul; 45(W1):W514-W522. PubMed ID: 28472504
[TBL] [Abstract][Full Text] [Related]
8. MutationalPatterns: comprehensive genome-wide analysis of mutational processes.
Blokzijl F; Janssen R; van Boxtel R; Cuppen E
Genome Med; 2018 Apr; 10(1):33. PubMed ID: 29695279
[TBL] [Abstract][Full Text] [Related]
9. The shaping of cancer genomes with the regional impact of mutation processes.
Lee SY; Wang H; Cho HJ; Xi R; Kim TM
Exp Mol Med; 2022 Jul; 54(7):1049-1060. PubMed ID: 35902761
[TBL] [Abstract][Full Text] [Related]
10. A site specific model and analysis of the neutral somatic mutation rate in whole-genome cancer data.
Bertl J; Guo Q; Juul M; Besenbacher S; Nielsen MM; Hornshøj H; Pedersen JS; Hobolth A
BMC Bioinformatics; 2018 Apr; 19(1):147. PubMed ID: 29673314
[TBL] [Abstract][Full Text] [Related]
11. Impact of cancer mutational signatures on transcription factor motifs in the human genome.
Yiu Chan CW; Gu Z; Bieg M; Eils R; Herrmann C
BMC Med Genomics; 2019 May; 12(1):64. PubMed ID: 31109337
[TBL] [Abstract][Full Text] [Related]
12. Topography of mutational signatures in human cancer.
Otlu B; Díaz-Gay M; Vermes I; Bergstrom EN; Zhivagui M; Barnes M; Alexandrov LB
Cell Rep; 2023 Aug; 42(8):112930. PubMed ID: 37540596
[TBL] [Abstract][Full Text] [Related]
13. Mutational signature SBS8 predominantly arises due to late replication errors in cancer.
Singh VK; Rastogi A; Hu X; Wang Y; De S
Commun Biol; 2020 Aug; 3(1):421. PubMed ID: 32747711
[TBL] [Abstract][Full Text] [Related]
14. Mutational Signatures in Cancer (MuSiCa): a web application to implement mutational signatures analysis in cancer samples.
Díaz-Gay M; Vila-Casadesús M; Franch-Expósito S; Hernández-Illán E; Lozano JJ; Castellví-Bel S
BMC Bioinformatics; 2018 Jun; 19(1):224. PubMed ID: 29898651
[TBL] [Abstract][Full Text] [Related]
15. Computational approaches for discovery of mutational signatures in cancer.
Baez-Ortega A; Gori K
Brief Bioinform; 2019 Jan; 20(1):77-88. PubMed ID: 28968631
[TBL] [Abstract][Full Text] [Related]
16. Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers.
Guo J; Zhou Y; Xu C; Chen Q; Sztupinszki Z; Börcsök J; Xu C; Ye F; Tang W; Kang J; Yang L; Zhong J; Zhong T; Hu T; Yu R; Szallasi Z; Deng X; Li Q
Cancer Res; 2021 Aug; 81(16):4205-4217. PubMed ID: 34215622
[TBL] [Abstract][Full Text] [Related]
17. AnnoMiner is a new web-tool to integrate epigenetics, transcription factor occupancy and transcriptomics data to predict transcriptional regulators.
Meiler A; Marchiano F; Haering M; Weitkunat M; Schnorrer F; Habermann BH
Sci Rep; 2021 Jul; 11(1):15463. PubMed ID: 34326396
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Mutational Signatures Using the mutSignatures R Library.
Fantini D; Meeks JJ
Methods Mol Biol; 2023; 2684():45-57. PubMed ID: 37410227
[TBL] [Abstract][Full Text] [Related]
19. decompTumor2Sig: identification of mutational signatures active in individual tumors.
Krüger S; Piro RM
BMC Bioinformatics; 2019 Apr; 20(Suppl 4):152. PubMed ID: 30999866
[TBL] [Abstract][Full Text] [Related]
20. Learning mutational signatures and their multidimensional genomic properties with TensorSignatures.
Vöhringer H; Hoeck AV; Cuppen E; Gerstung M
Nat Commun; 2021 Jun; 12(1):3628. PubMed ID: 34131135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
